| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.49 | 9e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |